[CAS NO. 2097416-76-5]  AZD0364 (ATG-017)

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [2097416-76-5]

Store
Catalog
SLK-S8708
Brand
Selleck
CAS
2097416-76-5

DESCRIPTION [2097416-76-5]

Overview

MDL-
Molecular Weight494.50
Molecular FormulaC24H24F2N8O2
SMILESO=C1C2=NC(C3=NC(NC4=CC=NN4C)=NC=C3C)=CN2C[C@H](COC)N1CC5=CC=C(F)C(F)=C5

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM2.0222 mL10.1112 mL20.2224 mL
5 mM0.4044 mL2.0222 mL4.0445 mL
10 mM0.2022 mL1.0111 mL2.0222 mL
50 mM0.0404 mL0.2022 mL0.4044 mL

Description

AZD0364 (ATG-017) is a pre-clinical inhibitor with an IC50 of 0.6 nM for ERK2.

Targets

ERK2 [1]
0.6 nM

In vitro

AZD0364 exhibits high cellular potency against a direct downstream substrate on the MAPK pathway (e.g. inhibition of phospho-p90RSK1 in BRAFV600E mutant A375 cells, IC50 = 6 nM). The molecule is a highly selective kinase inhibitor (10/329 kinases tested are inhibited at >50% at a 1 µM) and has long residence time on the protein (as determined by SPR on human unphosphorylated-ERK2: pKd = 10; t1/2 = 277 mins).